Not applicableActive Not RecruitingNCT06767020What this trial is testingComparative Study on AQP4 Antibody Detection MethodsWho this might be right forNMOSD First Affiliated Hospital of Chongqing Medical University 120
Not applicableStudy completedNCT07032337What this trial is testingEfficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum DisorderWho this might be right forNeuromyelitis Optica Spectrum Disorder (NMOSD) Samsung Medical Center 2,985
Not applicableLooking for participantsNCT07377305What this trial is testingEfficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)Who this might be right forNMO Spectrum Disorder Tang-Du Hospital 12
Not applicableEnded earlyNCT04131764What this trial is testingDiagnosis of ON With or Without MS or NMOSDWho this might be right forMultiple SclerosisNeuromyelitis Optica Spectrum Disorder AttackNeuromyelitis Optica Spectrum Disorder Relapse+2 more Jagannadha R Avasarala 112
Large-scale testing (Phase 3)Not Yet RecruitingNCT07132398What this trial is testingSlow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSDWho this might be right forNeuromyelitis Optica (NMO)Neuromyelitis Optica Spectrum Disorders (NMOSD) Tianjin Medical University General Hospital 170
Not applicableLooking for participantsNCT06940323What this trial is testingPregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)Who this might be right forMultiple SclerosisClinically Isolated SyndromeNMOSD+1 more University of California, San Francisco 250
Early research (Phase 1)Not Yet RecruitingNCT07573332What this trial is testingA Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsWho this might be right forAQP4+ NMOSD University of Texas Southwestern Medical Center 5
Not applicableLooking for participantsNCT07087873What this trial is testingAssessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating DiseasesWho this might be right forIdiopathic Inflammatory Demyelinating Disorders of the Central Nervous SystemMS (Multiple Sclerosis)NMOSD+2 more Xuanwu Hospital, Beijing 128
Large-scale testing (Phase 3)Study completedNCT04660539What this trial is testingEvaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)Who this might be right forNeuromyelitis Optica Spectrum Disorder Hoffmann-La Roche 119
Testing effectiveness (Phase 2)Looking for participantsNCT05504694What this trial is testingOfatumumab in AQP4-IgG Seropositive NMOSDWho this might be right forNeuromyelitis Optica Spectrum Disorder Tang-Du Hospital 5
Not applicableLooking for participantsNCT06865274What this trial is testingFrequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.Who this might be right forNeuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Large-scale testing (Phase 3)Study completedNCT02073279What this trial is testingEfficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)Who this might be right forNeuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD) Hoffmann-La Roche 95
Early research (Phase 1)Not Yet RecruitingNCT06633042What this trial is testingThe Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSDWho this might be right forAutoimmune Disease Bioray Laboratories 18
Very early researchNot Yet RecruitingNCT07592754What this trial is testingThe Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.Who this might be right forNeuromyelitis Optica Spectrum Disease (NMOSD) Chinese PLA General Hospital 18
Large-scale testing (Phase 3)Looking for participantsNCT05346354What this trial is testingEfficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDWho this might be right forNeuromyelitis Optica Spectrum Disorder Alexion Pharmaceuticals, Inc. 12
Very early researchLooking for participantsNCT06775912What this trial is testingClinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune DiseasesWho this might be right forSLESystemic SclerosisIIM+4 more Nanjing Bioheng Biotech Co., Ltd. 18
Not applicableStudy completedNCT03452176What this trial is testingScrambler Trial for Pain in NMOSDWho this might be right forNeuromyelitis Optica Johns Hopkins University 22
Not applicableNot Yet RecruitingNCT07159893What this trial is testingInectolizumab With Steroid Optimization in Newly Treated NMOSDWho this might be right forNeuromyelitis OpticaAutoimmune DiseasesDemyelinating Autoimmune Diseases, CNS First Affiliated Hospital of Wenzhou Medical University 25
Post-approval studies (Phase 4)Ended earlyNCT05269667What this trial is testingA Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An InterventionWho this might be right forNeuromyelitis Optica Spectrum DisorderNMOSD Hoffmann-La Roche 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06557174What this trial is testingEvaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) PatientsWho this might be right forNeuromyelitis Optica Spectrum Disorder (NMOSD) ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. 116